Peter Forsberg, David Andorsky, Robert M. Rifkin, Christopher A. Yasenchak, Mohit Narang, Jason M. Melear, Henning Helmut Schade, Mitul Gandhi, Gary Simmons, Muhamed Baljevic, Habte Aragaw Yimer, Kruti Patel, Amanda Lynn Gillespie-Twardy, Sudhir Manda, John Scott Renshaw, Jessica Fowler, Thomas S. Lin, Tonya Le Blanc, Weiming Xu. "Optec/Optal: A phase 2 study to evaluate outpatient (OP), step-up administration of teclistamab (Tec) or talquetamab (Tal) with prophylactic tocilizumab (prophyToci) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.7510